FDA
Cetrorelix Acetate
The FDA lists this product in 6 strengths and forms.
Composition
- Active ingredients
- CETRORELIX ACETATE EQ 0.25MG BASE/VIAL
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- CETRORELIX ACETATE EQ 0.25MG BASE/VIAL · PowderANDA218740-001 · Prescription
- CETRORELIX ACETATE EQ 0.25MG BASE/VIAL · PowderThis page
- CETRORELIX ACETATE EQ 0.25MG BASE/VIAL · PowderANDA214540-001 · Prescription
- CETRORELIX ACETATE EQ 0.25MG BASE/VIAL · PowderANDA218061-001 · Prescription
- CETRORELIX ACETATE EQ 0.25MG BASE/VIAL · PowderANDA215737-001 · Prescription
- CETRORELIX ACETATE EQ 0.25MG BASE/VIAL · PowderANDA218150-001 · Prescription
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application ANDA217776.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Cetrorelix Acetate
- Route
- Subcutaneous
- Dosage form
- Powder
- Applicant
- Qilu
- Status
- Prescription
- FDA approval
- 16 Apr 2024
- Application
- ANDA217776-001